<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html><!-- InstanceBegin template="../../../Templates/data.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<!-- InstanceBeginEditable name="doctitle" --> 
<TITLE>PNI.org | Pacific Neuropsychiatric Institute</TITLE>
<!-- InstanceEndEditable --> 
<META NAME="description" CONTENT="The Pacific Neuropsychiatric Institute
(PNI) is involved with comprehensive evaluation and management in
Neuropsychiatry and Psychopharmacology at the clinical, research,
forensic, education and phenomenologic levels.">
<META NAME="keywords" CONTENT="Vernon Neppe, medicine, psychopharmacology,
neuropsychiatry, forensic psychiatry, neuropsychiatric, institute,
education, lectures, brain, forensics, journal, internet journal, Neppe,
neurotransmitters, medical ethics, questionnaire, research instruments,
caffeine, philosophy, vortex pluralism, epileptology, anomalous, informed
consent, pharmacology, neuropsychology, clinical medicine, mental health,
brain injury, epilepsy, seizure, head injury, deja vu, anomalistic
experience, parapsychology, phenomenology, psychiatric, medical, drug,
BROCAS SCAN, STRAW, INSET, NMBPRS, PBRS, mental status, MMPI, SCL-90,
MMSE, Electroencephalogram, Electroencephalography, EEG, Ambulatory
monitoring, Ambulatory EEG, ventricular dilatation, MRI head, CT head,
SPECT head, PET head, competency, statistics, litigation, competence,
deposition, evidence, ethics, pharmacokinetics, pharmacodynamics, P450,
side-effects, tachyphylaxis, FDA, in vitro, in vivo, receptorology, civil
litigation, DSM, internet journal of Neuropsychiatry and
Psychopharmacology, JINEPP, INEPP, medical books, innovative
psychopharmacotherapy, partial agonist, agonist, antagonist, receptor,
synapse, autoreceptor, post-synaptic, pre-synaptic, down regulation, up
regulation, supersensitivity, subsensitivity, GABA, NMDA, receptor
subtypes, serotonin, norepinephrine, acetylcholine, benzodiazepine,
dopamine, opiates, chloride ionophore, pituitary, hypothalamus, temporal
lobe, frontal lobe, parietal lobe, occipital lobe, cerebral cortex,
kindling, chindling, bathtub, pushbuttons, motivation, MSE, mental status
examination, cognition, affect, volition, lesion localization,
psychomotor, dangerousness, environmental interaction, memory,
concentration, normality, organic brain syndrome, behavioral neurologist,
sleep, obesity, bariatric medicine, EMG, Electromyography, Nerve
conduction, antidepressant, anxiolytic, anxioselectivity, psychostimulant,
beta blocker, beta blockade, anticonvulsant, adjunctive therapy, appetite
suppressants, computer therapy, computerized diagnosis, memory retraining,
speech retraining, neuropharmacology, neuropharmacologist,
psychopharmacology, psychopharmacologist, anxiety, depression, OCD, ADD,
ADHD, attention deficit hyperactivity disorder, aggression, irritability,
tardive dyskinesia, movement disorder, neurology, Parkinson's, headache,
pain, sexual dysfunction, fibromyalgia, obsessive compulsive, Alzheimer's,
seizure, epilepsy, epileptic, TLE, CPS, closed head injury, CHIT, CHIP,
MTBI, PTSD, traumatic brain injury, methylphenidate, Ritalin, zolpidem,
Ambien, nadolol, Corgard, pemoline, Cylert, selegeline, nitrous oxide,
azapirones, phenytoin, Dilantin, topiramate, Topamax, tiagabine, Gabitril,
valproate, Depakote, felbamate, Felbatol, gabapentin, Neurontin,
carbamazepine, Tegretol, lamotrigine, Lamictal, neuroleptics, sumatriptan,
Imitrex, Sinemet, carbidopa, SSRI, sertraline, paroxetine, fluvoxamine,
fluoxetine, Zoloft, Paxil, Prozac, Luvox, bupropion, Wellbutrin, tricyclic
antidepressant, amitriptyline, imipramine, bromocriptine, Eldepryl,
Aricept, donepezil, pergolide, Cognex, tacrine, Parlodel, cyclobenzaprine,
Flexeril, phentermine, Buspar, buspirone, nefazodone, Serzone,
venlafaxine, Effexor, clozapine, Clozaril, perphenazine, Trilafon,
mirtazapine, Remeron, recreational drugs, firearms, cigarette, marijuana,
cannabinol, herbal remedies, St John's Wort, anti-oxidant,
proanthocyanadin, vitamin, mineral, melatonin, herbal, cannabis, tea,
coffee, cola drinks, pyridoxine, vitamin, mineral, ascorbic acid,
ascorbate, B6, anxiety, neurosis, depression, post-traumatic stress
disorder, Alzheimer's, dementia, cognitive deterioration, premenstrual
syndrome, PMS, panic, eating disorders, migraine, schizophrenia, bipolar
illness, manic, depression, mania, temporal lobe dysfunction, phobia,
pervasive developmental disorder, PDD, autism, obsessive compulsive
disordor, psychosis, refractory conditions, narcolepsy, drug abuse,
alcoholism, extrasensory perception, ESP, delta, psi, afferent, efferent,
subjective, vortex, paranormal, psychic, psychokinesis, PK, out of body
experience, OOBE, OBE, near death experience, NDE, survival, veridical,
dream, telepathy, clairvoyance, precognition, retrocognition, mediumship,
ectoplasm, aura, psychometry, remote viewing, Ganzfeld, deja entendu,
geomagnetic, deja pense, deja senti, deja pressenti, anomalous,
spontaneous, reincarnation, forced choice, Zener cards, experient,
non-experient, altered state, consciousness, phenomenologic">

<LINK REL="stylesheet" TYPE="text/css" HREF="../../../styles.css">

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">

<script language="JavaScript" type="text/JavaScript">
<!--
function MM_displayStatusMsg(msgStr) { //v1.0
  status=msgStr;
  document.MM_returnValue = true;
}
//-->
</script>
<!-- InstanceBeginEditable name="head" --><!-- InstanceEndEditable -->
</head>

<body text="#000000" link="#990000" vlink="#990000" alink="#990000" onLoad="MM_displayStatusMsg('PNI.org | Pacific Neuropsychiatric Institute');return document.MM_returnValue">
<a name="top"></a> 
<table width="700" border="1" align="center" cellpadding="0" cellspacing="0" bordercolor="#000000">
  <tr> 
    <td><table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="C4D2FF">
        <tr> 
          <td><a href="/"><img src="../../../header.jpg" width="700" height="127" border="0"></a></td>
        </tr>
        <tr>
          <td>
		  <div align="right">
				<a href="http://brainvoyage.com/" target="new_window">www.brainvoyage.com</a>
				 | <a href="http://vernonneppe.org/" target="new_window">www.vernonneppe.org</a>
				 | <a href="http://vernonneppe.com/" target="new_window">www.vernonneppe.com</a>
				 | <a href="http://ecao.us/" target="new_window">www.ecao.us</a>
				 | <a href="http://healthyharmony.com/" target="new_window">www.healthyharmony.com</a>&nbsp;
			</div>
			<div align="left" >
				<script>
				  (function() {
					var cx = '009175660163571863627:du9tocqgd6q';
					var gcse = document.createElement('script');
					gcse.type = 'text/javascript';
					gcse.async = true;
					gcse.src = 'https://cse.google.com/cse.js?cx=' + cx;
					var s = document.getElementsByTagName('script')[0];
					
					s.parentNode.insertBefore(gcse, s);
				  })();
				</script>
				<gcse:search></gcse:search>
			</div>
			<table width="100%" border="0" cellspacing="0" cellpadding="15">
              <tr>
                <td width="100%"><p><font size="3" face="Arial, Helvetica, sans-serif"><strong>
                    <a href="http://pni.org/neuropsychiatry/">NEUROPSYCHIATRY and BEHAVIORAL NEUROLOGY</a>
                     | 
                    <a href="http://pni.org/psychopharmacology/">PSYCHOPHARMACOLOGY</a><br><a href="http://pni.org/forensics/">FORENSICS</a> | <a href="/research/">RESEARCH</a>
					 | 
                    <a href="http://pni.org/consciousness/">CONSCIOUSNESS</a>
					 | 
                    <a href="http://pni.org/philosophy/">PHILOSOPHY</a> | <a href="http://www.brainvoyage.com/ctbm/">BOOKS</a> | <a href="/books/">LITERATURE</a><br>
                    <a href="http://pni.org/perspective.html">PERSPECTIVES</a>
                    | <a href="http://pni.org/clinical/">CLINICAL</a> | <a href="http://pni.org/research/anomalous/deja/">D&Eacute;J&Agrave; VU</a> | 
                    <a href="http://pni.org/interesting/">INTERESTING AREAS</a> | <a href="http://pni.org/philosophy/ethics/">ETHICS</a>
                    | <a href="http://pni.org/about_pni.html">CONTACT</a></strong></font></p>
                <p>
					<strong>
						KEY ARTICLES (MEDICAL):
						<a href="http://pni.org/neuropsychiatry/chit/">HEAD INJURY</a> | 
						<a href="http://pni.org/neuropsychiatry/narcolepsy/">NARCOLEPSY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/paroxysmal/">PAROXYSMAL DISORDERS</a> | 
						<a href="http://pni.org/psychopharmacology/principles/">PRESCRIPTION PRINCIPLES</a> | 
						<a href="http://www.pni.org/psychopharmacology/generics">GENERIC SUBSTITUTION</a> | 
						<a href="http://www.pni.org/neuropsychiatry/tardive_dyskinesia/">TARDIVE DYSKINESIA</a> |
						<a href="http://pni.org/key-articles/double-blind.html">DOUBLE BLIND</a>
						</strong>
						<p>
					<strong>
						ENDURING INTEREST:
						<a href="http://www.pni.org/groundbreaking/">GROUNDBREAKING PARADIGM SHIFTS</a> | 
						<a href="http://www.pni.org/philosophy/">PHILOSOPHY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/moral_philosophy/">MORAL PHILOSOPHY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/consciousness/">CONSCIOUSNESS</a> | 
						<a href="http://pni.org/key-articles/deja-vu.html">DEJA VU</a> | 
						
						<a href="http://www.pni.org/intelligence/">GENIUS</a> | 
						
						<a href="http://www.pni.org/ethics/security/">ZMAIL</a>					
					 </strong>
				</td>
              </tr>
            </table>
            <table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tr> 
                <td class="bodyText" valign="top"><!-- InstanceBeginEditable name="content" --> 
                  <table width="650" border="0" align="center" cellpadding="5" cellspacing="0">
                    <tr> 
                      <td width="74%" valign="top"> <h2>Caffeine</h2>
                        <P>BACKGROUND<BR>
                          Caffeine, nicotine and alcohol are probably the three 
                          most widely used psychoactive chemical agents in the 
                          world. Caffeine is generally used as a beverage in coffee, 
                          tea and soda pop drinks. It is non-prescription drug 
                          where per capita intake for the entire world's population 
                          approximates 70 mg a day, but in the United States that 
                          figure exceeds 200 mg. and four out of five adult Americans 
                          report regular intake.</P>
                        <P>Caffeine's use apparently dates back thousands of years 
                          - tea in China to 5000 years ago, Coffee beans in Africa 
                          to 1500 years ago, Coffee in Arabia to 800 years ago.</P>
                        <P>Pharmacologically, caffeine belongs to a brain stimulant 
                          group of alkaloids called methylxanthines (also called 
                          xanthines). Theophylline and Theobromine are also Xanthines.</P>
                        <P>&nbsp;</P>
                        <P>OCCURRENCE<BR>
                          It occurs naturally in some plants nuts, seeds or leaves.</P>
                        <P>e.g. Coffee from the Coffea arabica plant;</P>
                        <P>soft drinks, like Cola drinks, made from Kola nuts 
                          ( but less than 5% of the caffeine is from the kola 
                          nut; the other 95% uses the decaffeination extract process 
                          results)</P>
                        <P>tea leaves from Thea sinensis.</P>
                        <P>Cocoa is from the seeds of the Theobroma cocoa plant 
                          (or cocoa beans) and is used to make chocolate, chocolate 
                          milk, hot cocoa, and various other candies. This contains 
                          mainly theobromine. A candy bar (3.5 ounces) may contain 
                          caffeine (e.g. 12 mg) and theobromine (e.g. 155 mg) 
                          and a 5 ounce hot cocoa cup, 10 mg caffeine and 200 
                          mg theobromine.<BR>
                          <BR>
                        </P>
                        <P>CAFFEINE USES:<BR>
                          1. Food additive :This is regulated by the Federal Food 
                          and Drug Administration (FDA) with a label insert when 
                          caffeine has been added.</P>
                        <P>2. Natural usage of Caffeine need not be on the label.e.g. 
                          coffee, tea, soft drinks, chocolate candy bars</P>
                        <P>3. Over-the-counter and prescription medications e.g. 
                          stimulants with antimigraine or antihistamine drugs, 
                          cold remedies, and pain killers. Use relates to management 
                          of side-effects or symptoms of fatigue and hyperactivity 
                          (questionable).<BR>
                        </P>
                        <P>PHARMACOLOGICAL EFFECTS<BR>
                          Biological effects of caffeine in animals and man depend 
                          on the dose, method of administration and duration of 
                          exposure.</P>
                        <P>Technically, caffeine enhances CNS norepinephrine secretion, 
                          inhibits phosphodiesterase breakdown of cyclic 3',5'-adenosine 
                          monophosphate (cAMP) at high concentrations, sensitizes 
                          central catecholamine postsynaptic receptors (including 
                          those for dopamine), enhances cyclic guanosine 3',5'-monophosphate 
                          (cGMP), and modulates acetylcholine and serotonin activity. 
                          Caffeine induces significant increases in cortisol, 
                          but no meaningful change in prolactin.</P>
                        <P>Caffeine's ability to antagonize adenosine receptors 
                          in the brain probably accounts for the most important 
                          of the drug's behavioral effects. Adenosine is an important 
                          CNS neuromodulator, possessing sedative, anxiolytic, 
                          and anticonvulsant properties. Adenosine also dilates 
                          blood vessels in cerebral and coronary circulatory networks. 
                          Caffeine competes with adenosine for binding at its 
                          high-affinity receptor sites, preventing adenosine's 
                          normal tranquilizing or sedating effects. Thus, caffeine's 
                          stimulant or anxiety-inducing actions appear to be secondary 
                          effects of adenosine antagonism. Chronic caffeine exposure 
                          has also been shown to induce heterologous up-regulation 
                          of adenosine receptors in humans. Caffeine's antagonism 
                          to vasodilation by adenosine may account for caffeine 
                          withdrawal headaches, as well as for its efficacy in 
                          treating migraine headaches. <BR>
                        </P>
                        <P>Positron emission tomography (PET) imaging studies 
                          confirm that a caffeine dose of 200 mg produces a diffusely 
                          decreases cerebral blood flow by about a third within 
                          an hour of administration<BR>
                        </P>
                        <P>MEDICAL EFFECTS<BR>
                          Caffeine is a mild stimulant and people have variable 
                          sensitivity to caffeine. Caffeine does not accumulate 
                          in the blood and is normally excreted within several 
                          hours. It can speed reaction time, prolong vigilance 
                          but will not help people &quot;sober up&quot; to too 
                          much alcohol.<BR>
                        </P>
                        <P>Caffeine is the <I>single most important cause of anxiety 
                          in our society</I> and doses like 1000 mg per day is 
                          anxiety evoking in almost everyone and many are exquisitely 
                          sensitive e.g. 50 mg or 100 mg. This may lead to misdiagnoses 
                          of Panic or Generalized Anxiety Disorder. Caffeine may 
                          impair sleep in sensitive individuals and is not advised 
                          at night in insomniacs.<BR>
                          In addition to other psychiatric or medical conditions, 
                          concomitant use of other psychoactive agents, such as 
                          nicotine, alcohol, or benzodiazepines, is common in 
                          caffeine users. This often confounds an accurate diagnosis.<BR>
                        </P>
                        <P>Caffeine is, at this point, regarded as safe for long 
                          term use in regard to its physical effects:<BR>
                          * May 1987, FDA &quot;studies on teratology, reproduction 
                          behavior, carcinogenicity, and cardiovascular disease...found 
                          no evidence to show that the use of caffeine in carbonated 
                          beverages would render these beverages injurious to 
                          health.&quot; <BR>
                          * 1984 AMA Council on Scientific Affairs &quot;Moderate 
                          tea or coffee drinkers probably need have no concern 
                          for their health relative to their caffeine consumption 
                          provided other lifestyle habits (diet, alcohol consumption) 
                          are moderate, as well.&quot; <BR>
                        </P>
                        <P>Available information does not suggest a recommendation 
                          against the moderate use of coffee unless it is known 
                          to cause specific symptoms, like anxiety, agitation 
                          or palpitations, in the individual using it. There is 
                          no indication that caffeine, a natural component of 
                          both coffee and tea, is a risk factor in human cancer.<BR>
                        </P>
                        <P>Coffee, tea and other caffeinated beverages do not 
                          cause any persistent increase in blood pressure.though 
                          some individuals may experience a small, short-lived 
                          rise in blood pressure usually not lasting more than 
                          several hours.<BR>
                          Most scientific research does not support a link between 
                          caffeine consumption and cardiovasculardisease - weak 
                          and inconsistent evidence or 1989 Framingham Heart Study 
                          &quot;no deleterious or salutary effect of coffee consumption.&quot;</P>
                        <P>1990 Harvard University study: Caffeine intake does 
                          not appreciably increase the risk of coronary heart 
                          disease or stroke. Individual patients may find the 
                          frequency or severity of cardiac arrhythmias increasing, 
                          but generally not.<BR>
                        </P>
                        <P>Three major studies involving more than 15,000 women 
                          have found no birth defects associated with caffeine 
                          consumption. Even offspring of the heaviest coffee drinkers 
                          were not found to be at higher risk of birth defects, 
                          spontaneous abortion or preterm delivery, or dysmaturity.<BR>
                          The most recent FDA animal studies have found no birth 
                          defects when rats are given high doses of caffeine in 
                          their drinking water. These results contradict earlier 
                          FDA research in 1980 that had triggered an advisory 
                          to pregnant women to avoid caffeine involving force-fed 
                          rats high doses of caffeine all at once through stomach 
                          tubes (gavage).<BR>
                        </P>
                        <P>Caffeine may adversely affect reproduction in humans 
                          , but variables in like exercise level, dietary habits, 
                          stress, were not controlled. <BR>
                        </P>
                        <P>Children are no more sensitive to caffeine's potential 
                          effects than adults and it may be eliminated from the 
                          body twice as rapidly in children than adults. <BR>
                        </P>
                        <P>Caffeine consumption patterns differ somewhat from 
                          drugs of dependence.</P>
                        <P>1. It does not result in steadily increased doses over 
                          short periods. However, caffeine use generally increases 
                          gradually over the years). Consumption often surges 
                          during college years, for both social reasons and for 
                          enhancing alertness and opposing sleep.<BR>
                        </P>
                        <P>2. Caffeine withdrawal headaches (tapering by half 
                          cup per day may diminish) occur but generally one can 
                          get off it. Also irritability and anxiety may occur.<BR>
                          <BR>
                        </P>
                        <P><B>Theophylline</B> pharmacologically is a beta adrenergic 
                          stimulant: it is commonly used in asthma as a bronchodilator, 
                          and sometimes in congestive heart failure in very high 
                          doses (500-750 mg). This can have potentially cause 
                          marked stimulation: tea contains a fraction of this 
                          amount..<BR>
                          <BR>
                        </P>
                        <P>CAFFEINE CONTENT OF VARIOUS DRINKS:</P>
                        <P>&nbsp;</P>
                        <P><I>PERSPECTIVE</I>: : <I>Amounts in common drinks.</I></P>
                        <P>Coffee contains Caffeine alone e.g. 100 mg</P>
                        <P>Tea contains Caffeine e.g. 40mg , Theophylline e.g. 
                          1 mg of theophylline (less potent stimulant than caffeine) 
                          and Theobromine which is a far less potent stimulant 
                          but may have diuretic effects.</P>
                        <P>A soft cola or pop drink contains e.g. 50 mg Caffeine 
                          (12 ounce not 5 ounce like tea or coffee cups) and of 
                          course no Cocaine.</P>
                        <P><I>AMPLIFICATION:</I><BR>
                          <BR>
                          Effects are additive: a cup of coffee plus 2 cups of 
                          tea and an over the counter preparation together may 
                          produce toxic effects. <BR>
                        </P>
                        <P>The caffeine content of an average cup of coffee (5 
                          ounce ) is actually variable : range 40 mg -150 mg, 
                          of tea range 20-ll0 mg, of soda pops 30 mg to 60 mg<BR>
                        </P>
                        <P>Dosage of caffeine in coffee depends on coffee bean 
                          , origin (geography, soil, growing season length), harvest, 
                          degree of fine grinding, brew length and method.</P>
                        <P>Similarly, dosage of caffeine of tea will depend upon 
                          the type of tea used, the tea leaf cut, and how long 
                          it was brewed.</P>
                        <P>Dosage of caffeine in soda pops will depend mainly 
                          upon the decaffeination extraction process from which 
                          it was derived and also on the Kola nut (slight). Soft 
                          drinks containing caffeine will show it as an ingredient 
                          on the product label and the level of caffeine in a 
                          particular brand is consistent from can to can because 
                          of strict manufacturing controls. <BR>
                          <BR>
                        </P>
                        <P>USING A 5 OUNCE CUP SIZE: <I>some guidelines</I></P>
                        <P>Coffee via drip method, with fine ground, in machines 
                          e.g.110-150 mg</P>
                        <P>Percolated coffee 64-124 mg.</P>
                        <P>Instant coffee 40-108 mg. <BR>
                        </P>
                        <P>Tea 1 min. brew 9 mg -33 mg</P>
                        <P>5 min. brew 20 mg -50 mg</P>
                        <P>Instant tea 12 mg -28 mg<BR>
                        </P>
                        <P>Percolated Decaffeinated coffee 2-5 mg</P>
                        <P>Instant Decaffeinated coffee 2 mg</P>
                        <P>Decaffeinated soft drinks 0 mg to 0.09mg (virtually 
                          none) <BR>
                        </P>
                        <P>(Consumers' Union, FDA, National Coffee Association 
                          of the U.S.A., and National Confectioner's Association 
                          of the U.S., www. /net-abuse.org/~lizardo/caff.sources.html) 
                          <BR>
                        </P>
                        <P>12 0UNCE DRINKS:<BR>
                        </P>
                        <P>Iced tea 22-36 mg</P>
                        <P>Soft drinks vary greatly:</P>
                        <P>Jolt 72.0 mg</P>
                        <P>Sugar-Free Mr. Pibb 58.8 mg</P>
                        <P>Mountain Dew 54.0 mg</P>
                        <P>Mello Yello 52.8 mg</P>
                        <P>TAB 46.8 mg</P>
                        <P>Coca-Cola 45.6 mg</P>
                        <P>Diet Coke 45.6 mg</P>
                        <P>Shasta Cola 44.4 mg</P>
                        <P>Shasta Cherry Cola 44.4 mg</P>
                        <P>Shasta Diet Cola 44.4 mg</P>
                        <P>Shasta Diet Cherry Cola 44.4 mg</P>
                        <P>Mr. PIBB 40.8 mg</P>
                        <P>Dr. Pepper 39.6 mg</P>
                        <P>Big Red 38.4 mg</P>
                        <P>Sugar-Free Dr. Pepper 39.6 mg</P>
                        <P>Pepsi-Cola 38.4 mg</P>
                        <P>Aspen 36.0 mg</P>
                        <P>Diet Pepsi 36.0 mg</P>
                        <P>Pepsi Light 36.0 mg</P>
                        <P>RC Cola 36.0 mg</P>
                        <P>Diet Rite 36.0 mg</P>
                        <P>Kick 31.2 mg</P>
                        <P>Canada Dry Jamaica Cola 30.0 mg</P>
                        <P>Canada Dry Diet Cola 1.2 mg</P>
                        <P>[National Soft Drink Association , www. net-abuse.org/~lizardo/caff.sources.html] 
                          <BR>
                          <BR>
                        </P>
                        <P>THE PROCESS OF DECAFFEINATION</P>
                        <P>Two basic decaffeination processes are used in the 
                          U.S.A :</P>
                        <P>1. water extraction :</P>
                        <P>a. coffee beans are steamed and then soaked and then 
                          rinsed,</P>
                        <P>b. caffeine diffuses from the beans into the water,</P>
                        <P>v. uses no artificial chemicals.<BR>
                        </P>
                        <P>2. direct solvent extraction:</P>
                        <P>a. direct application of methylene chloride, ethyl 
                          acetate or carbon dioxide to the coffee beans</P>
                        <P>b . coffee beans are then steamed to remove the residual 
                          solvent, then dried and roasted.</P>
                        <P>Methylene chloride may when inhaled be an animal carcinogen 
                          but to mice in drinking water was not.</P>
                        <P>The FDA regards its potential health risk as so low 
                          &quot;as to be essentially non-existent&quot; (FDA, 
                          1985). <BR>
                          <BR>
                          <BR>
                        </P>
                        <P>OVER-THE-COUNTER MEDICATIONS (FDA regulated; based 
                          per tablet) <BR>
                        </P>
                        <P>Stimulants<br>
                          NoDoz tablets 100<br>
                          Vivarin tablets 200<br>
                        </P>
                        <P>Pain Relievers<br>
                          Anacin 32<br>
                          Excedrin 65<br>
                          Excedrin P.M. 0<br>
                          Midol 32<br>
                          Vanquish 33<br>
                        </P>
                        <P>Cold Remedies<br>
                          Coryban-D 30<BR>
                        </P>
                        <P>[FDA's Center for Drugs and Biologics; www. net-abuse.org/~lizardo/caff.sources.html] 
                          <BR>
                          <BR>
                        </P>
                        <P>SHORT BIBLIOGRAPHY<BR>
                        </P>
                        <P>Sources above include the following websites:<br>
                          www.vhs.com/caffeine.html,<br>
                          www. net-abuse.org/~lizardo/caff.sources.html<BR>
                        </P>
                        <P>Barone J J, Roberts H: Human consumption of caffeine. 
                          In Caffeine, P B Dews, editor, p 59. Springer-Verlag, 
                          New York, 1984.</P>
                        <P>Benowitz N L: Clinical pharmacology of caffeine. Ann 
                          Rev Med 41: 277, 1990.</P>
                        <P>Benton D : Caffeine: use and abuse . <I>Nurs Stand</I> 
                          1989 ; 44 (3 ): 34-6 .</P>
                        <P>Bruce MS , Lader, M : Caffeine abstention in the management 
                          of anxiety disorders . <I>Psychol Med</I> 19 (1 ): 211-4, 
                          1989. </P>
                        <P>Cameron O G, Modell J G, Hariharan M: Caffeine and 
                          human cerebral blood flow: A positron emission study. 
                          Life Sci 47: 1141, 1990. </P>
                        <P>Carroll ME, Hagen, EW, Asencio, M , Brauer, LH : Behavioral 
                          dependence on caffeine and phencyclidine in rhesus monkeys: 
                          interactive effects . <I>Pharmacol Biochem Behav</I> 
                          31 (4 ): 927-32, 1988. </P>
                        <P>Charney D S, Heninger G R, Jatlow P I: Increased anxiogenic 
                          effects of caffeine in panic disorder. Arch Gen Psychiatry 
                          42: 233, 1985. </P>
                        <P>Clementz GL , Dailey, JW : Psychotropic effects of 
                          caffeine . <I>Am Fam Physician</I> 37 (5 ): 167-72, 
                          1988.</P>
                        <P>Conlay LA, Evoniuk, G , Wurtman, RJ : Endogenous adenosine 
                          and hemorrhagic shock: effects of caffeine administration 
                          or caffeine withdrawal . <I>Proc Natl Acad Sci U S A</I> 
                          85 (12 ): 4483-5, 1988.</P>
                        <P>Couturier E G, Hering R, Steiner T J: Weekend attacks 
                          in migraine patients: Caused by caffeine withdrawal? 
                          Cephalalgia 12: 99, 1992. </P>
                        <P>Diener HC, Dichgans, J, Scholz, E, Geiselhart, S, Gerber, 
                          WD , Bille, A : Analgesic-induced chronic headache: 
                          long-term results of withdrawal therapy . <I>J Neurol</I> 
                          236 (1 ): 9-14 , 1989. </P>
                        <P>Dunbar GC, Morgan, DD , Perera, KM : The concurrent 
                          use of alcohol, cigarettes and caffeine in British benzodiazepine 
                          users as measured by a general population survey . <I>Br 
                          J Addict</I> 83 (6 ): 689-94, 1988.</P>
                        <P>Fennelly M, Galletly D C, Purdie G I: Is caffeine withdrawal 
                          the mechanism of postoperative headache? Anesth Analg 
                          72: 449, 1991. </P>
                        <P>Goldstein A, Kaizer S, Whitby O: Psychotropic effects 
                          of caffeine in man. IV. Quantitative and qualitative 
                          differences associated with habituation to caffeine. 
                          Clin Pharmacol Ther 10: 489, 1969. </P>
                        <P>Graham K : Reasons for consumption and heavy caffeine 
                          use: generalization of a model based on alcohol research 
                          . <I>Addict Behav</I> 13 (2 ): 209-14, 1988.</P>
                        <P>Greden J F: Anxiety and depression associated with 
                          caffeinism among psychiatric inpatients. Am J Psychiatry 
                          135: 963, 1978. </P>
                        <P>Greden, JF , Pomerleau, O. Caffeine-Related Disorders 
                          And Nicotine-Related Disorders - in Comprehensive Textbook 
                          of Psychiatry Sixth Edition. Williams and Wilkins. Baltimore. 
                          1996</P>
                        <P>Griffiths R R, Bigelow G E, Liebson I A: Human coffee 
                          drinking: Reinforcing and physical dependence producing 
                          effects of caffeine. J Pharmacol Exp Ther 239: 416, 
                          1986.</P>
                        <P>Griffiths RR , Woodson, PP : Caffeine physical dependence: 
                          a review of human and laboratory animal studies . <I>Psychopharmacology 
                          (Berlin)</I> 94 (4 ): 437-51, 1988.</P>
                        <P>Griffiths RR, Bigelow, GE , Liebson, IA : Reinforcing 
                          effects of caffeine in coffee and capsules . <I>J Exp 
                          Anal Behav</I> 52 (2 ): 127-40, 1989.</P>
                        <P>Griffiths R R, Evans S M, Heishman S J, Preston K L, 
                          Sannerud C A, Wolf B, Woodson P P: Low-dose caffeine 
                          physical dependence in humans. J Pharmacol Exp Ther 
                          255: 1123, 1990.</P>
                        <P>Hughes J R, Higgins S T, Bickel W K: Caffeine self-administration, 
                          withdrawal, and adverse effects among coffee drinkers. 
                          Arch Gen Psychiatry 48: 611, 1991.</P>
                        <P>Hughes J R, Oliveto A H, Helzer J E, Higgins S T, Bickel 
                          W K: Should caffeine abuse, dependence, or withdrawal 
                          be added to DSM-IV and ICD-10? Am J Psychiatry 149: 
                          33, 1992.</P>
                        <P>James JE, Paull, I, Cameron, TE, Miners, JO , Birkett, 
                          DJ : Biochemical validation of self-reported caffeine 
                          consumption during caffeine fading . <I>J Behav Med</I> 
                          11 (1 ): 15-30, 1988.</P>
                        <P>Johnson GD, Fatis, M, Sonnek, D , Shawchuck, C : A 
                          survey of caffeine use and associated side effects in 
                          a college population . <I>J Drug Educ</I> 18 (3 ): 211-20, 
                          1988.</P>
                        <P>Kirmer DA : Caffeine use and abuse in psychiatric clients 
                          . <I>J Psychosoc Nurs Ment Health Serv</I> 26 (11 ): 
                          20-5 , 1988.</P>
                        <P>Koczapski A, Paredes, J, Kogan, C, Ledwidge, B , Higenbottam, 
                          J : Effects of caffeine on behavior of schizophrenic 
                          inpatients . <I>Schizophr Bull</I> 15 (2 ): 339-44 , 
                          1989.</P>
                        <P>Kuribara H, Tadokoro S: Caffeine does not effectively 
                          ameliorate, but rather may worsen the ethanol intoxication 
                          when assessed by discrete avoidance in mice. Jpn J Pharmacol 
                          59: 393, 1992.</P>
                        <P>Lee MA, Flegel, P, Greden, JF , Cameron, OG : Anxiogenic 
                          effects of caffeine on panic and depressed patients 
                          . <I>Am J Psychiatry</I> 145 (5 ): 632-5, 1988.</P>
                        <P>Lee MA, Flegel, P, Cameron, OG , Greden, JF : Chronic 
                          caffeine consumption and the dexamethasone suppression 
                          test in depression . <I>Psychiatry Res</I> 24 (1 ): 
                          61-5 , 1988.</P>
                        <P>Levinson H C, Bick E C: Psychopharmacology of caffeine. 
                          In Psychopharmacology in the Practice of Medicine, M 
                          D Jarvik, editor, p 451. Appelton-Century-Crofts, New 
                          York, 1977.</P>
                        <P>McGowan JD, Altman, RE , Kanto, WJ : Neonatal withdrawal 
                          symptoms after chronic maternal ingestion of caffeine 
                          . <I>South Med J</I> 81 (9 ): 1092-4, 1988.</P>
                        <P>Paul S, Kurunwune B, Biaggioni I; Caffeine withdrawal: 
                          Apparent heterologous sensitization to adenosine and 
                          prostacyclin actions in human platelets. J Pharmacol 
                          Exp Ther 267: 838, 1993.</P>
                        <P>Russ NW, Sturgis, ET, Malcolm, RJ , Williams, L : Abuse 
                          of caffeine in substance abusers [letter] . <I>J Clin 
                          Psychiatry</I> 49 (11 ), 1988.<BR>
                        </P>
                        <P>Silverman K, Evans S M, Strain E C, Griffiths R R: 
                          Withdrawal syndrome after the double-blind cessation 
                          of caffeine consumption. N Engl J Med 327: 1109, 1992.<BR>
                        </P>
                        <P>Snyder S H, Katims J J, Annau Z, Bruns R F, Daly J 
                          W: Adenosine receptors and behavioral actions of methylxanthines. 
                          Proc Natl Acad Sci USA 78: 3260, 1981.<BR>
                        </P>
                        <P>Stein MB , Uhde, TW : Depersonalization disorder: effects 
                          of caffeine and response to pharmacotherapy . <I>Biol 
                          Psychiatry</I>; 26 (3 ): 315-20, 1989</P>
                        <P>Stern KN, Chait, LD , Johanson, CE : Reinforcing and 
                          subjective effects of caffeine in normal human volunteers 
                          . <I>Psychopharmacology (Berlin)</I> 98 (1 ): 81, 1989.<BR>
                        </P>
                        <P>Winstead D K: Coffee consumption among psychiatric 
                          inpatients. Am J Psychiatry, 133: 1447, 1976.</P>
                        <H2>&nbsp;</H2>
                        <P align="right"><font face="Arial, Helvetica, sans-serif"><a href="#top"><img src="../../../top.gif" width="48" height="19" border="0"></a></font></P></td>
                    </tr>
                  </table>
                  <p>&nbsp;</p>
                  <!-- InstanceEndEditable -->
<p>&nbsp;</p>
				  </td>
              </tr>
            </table>
            
          </td>
        </tr>
        <tr>
          <td height="29"><img src="../../../bottom.jpg" width="700" height="29" border="0" usemap="#Map3"></td>
        </tr>
      </table></td>
  </tr>
</table>
<p align="center"><br>
  <font size="2" face="Arial, Helvetica, sans-serif">Copyright &copy;1997-2018 
  Pacific Neuropsychiatric Institute</font><br>
</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<map name="Map3">
  <area shape="rect" coords="237,3,385,23" href="http://pni.org/about_pni.html">
  <area shape="rect" coords="410,5,566,25" href="http://www.pni.org/disclaimer.html">
  <area shape="rect" coords="582,3,682,26" href="http://www.pni.org/credits.html">
</map>
</body>
<!-- InstanceEnd --></html>
